We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
MicroRNAs as Predictors of Future Uterine Malignancy in Endometrial Hyperplasia without Atypia.
- Authors
Lin, Chiao-Yun; Wu, Ren-Chin; Yang, Lan-Yan; Jung, Shih-Ming; Ueng, Shir-Hwa; Tang, Yun-Hsin; Huang, Huei-Jean; Tung, Hsiu-Jung; Lin, Cheng-Tao; Chen, Hsuan-Yu; Chao, Angel; Lai, Chyong-Huey
- Abstract
The histological criteria for classifying endometrial hyperplasia (EH) are based on architectural crowding and nuclear atypia; however, diagnostic agreement among pathologists is poor. We investigated molecular biomarkers of endometrial cancer (EC) risk in women with simple hyperplasia or complex hyperplasia without atypia (SH/CH-nonA). Forty-nine patients with EC preceded by SH/CH-nonA were identified, of which 23 were excluded (15 with complex atypical hyperplasia (CAH), six not consenting, one with a diagnosis < 6 months prior, and one lost to follow-up). The EH tissues of these patients were compared with those of patients with SH/CH-nonA that did not progress to EC (control) through microRNA (miRNA) array analysis, and the results were verified in an expanded cohort through reverse transcription-quantitative polymerase chain reaction (RT-qPCR). MiRNA arrays analyses revealed 20 miRNAs that differed significantly (p < 0.05, fold change > 4) between the control (n = 12) and case (n = 6) patients. Multiplex RT-qPCR for the 20 miRNAs in the expanded cohort (94 control and 25 case patients) led to the validation of miR-30a-3p (p = 0.0009), miR-141 (p < 0.0001), miR-200a (p < 0.0001), and miR-200b (p < 0.0001) as relevant biomarkers, among which miR-141, miR-200a, and miR-200b regulate the expression of phosphatase and tensin homolog (PTEN). For the prediction of EC, the area under the curve for miR-30a-3p, miR-141, miR-200a, and miR-200b was 0.623, 0.754, 0.783, and 0.704, respectively. The percentage of complete PTEN loss was significantly higher in the case group than in the control group (24% vs. 0%, p < 0.001, Fisher's exact test). A combination of complete PTEN loss and miR-200a provided optimal prediction performance (sensitivity = 0.760; specificity = 1.000; positive predictive value = 1.000; negative predictive value = 0.937; accuracy = 0.947). MiR-30a-3p, miR-141, miR-200a, miR-200b, and complete PTEN loss may be useful tissue biomarkers for predicting EC risk among patients with SH/CH-nonA.
- Subjects
ENDOMETRIAL hyperplasia; PTEN protein; MICRORNA; FISHER exact test; POLYMERASE chain reaction
- Publication
Journal of Personalized Medicine, 2022, Vol 12, Issue 2, pN.PAG
- ISSN
2075-4426
- Publication type
Article
- DOI
10.3390/jpm12020311